Lungs Bioregulator (Taxorest): Peptide Science for Respiratory and Bronchial Health
# Lungs Bioregulator (Taxorest): Peptide Science for Respiratory and Bronchial Health
We take approximately 20,000 breaths per day. Each one draws air through a respiratory tree that branches 23 times before reaching the 300 million alveoli where gas exchange actually occurs. The surface area of the lungs — if you could spread it flat — would cover roughly the size of a tennis court. It is an astonishing organ, and one that takes relentless abuse from the environment.
In my 20 years of nursing, I have cared for patients across the spectrum of respiratory disease — from acute pneumonia to chronic obstructive pulmonary disease (COPD), from asthma exacerbations to post-surgical atelectasis. What strikes me most is how slowly respiratory decline creeps in. By the time most people notice breathing difficulty, significant lung function has already been lost.
That is why I want to discuss Taxorest (A-19), a bovine lung peptide bioregulator from the Nature's Marvels line of Khavinson peptides.
The Lungs: An Organ Under Constant Assault
The respiratory system faces unique challenges that no other organ deals with:
- Direct environmental exposure: Every breath carries potential irritants — pollution, allergens, microbes, particulate matter
- Massive surface area: The enormous gas-exchange surface means a huge area vulnerable to damage
- Constant mechanical stress: The continuous expansion and contraction of breathing subjects lung tissue to lifelong mechanical strain
- Oxidative burden: The lungs are exposed to higher oxygen concentrations than any other internal organ, creating significant oxidative stress
Age-related changes in lung function are well documented. After age 25-30, forced expiratory volume (FEV1) declines by approximately 25-30 mL per year in healthy non-smokers — and much faster in those with respiratory risk factors (Sharma & Goodwin, 2006, *Clinical Interventions in Aging*, 1(3), 253-260).
These changes include:
- Decreased elastic recoil — the lung tissue becomes less springy
- Reduced mucociliary clearance — the self-cleaning mechanism slows down
- Weakened immune surveillance — alveolar macrophages become less effective
- Epithelial thinning — the bronchial lining becomes more vulnerable to infection and injury
- Decreased surfactant production — the substance that keeps alveoli from collapsing
What Is Taxorest?
Taxorest is a peptide bioregulator containing short-chain peptides (2-4 amino acids) extracted from bovine lung tissue. Developed as part of Professor Vladimir Khavinson's bioregulator system at the St. Petersburg Institute of Bioregulation and Gerontology, Taxorest is designed to interact selectively with DNA in pulmonary cells to support normal gene expression related to respiratory function.
Each box of Nature's Marvels Taxorest contains 20 HPMC vegan capsules with the bovine-derived lung peptide complex.
The Research: Pulmonary Peptides and Respiratory Health
Taxorest Clinical Research
Taxorest has been studied in clinical trials within the Russian Federation, where peptide bioregulators have regulatory status and clinical application history. Published research on Taxorest has reported:
- Improved pulmonary function test parameters (FEV1, FVC) in patients with chronic respiratory conditions
- Enhanced mucociliary clearance
- Improved subjective respiratory symptoms — less dyspnea, better exercise tolerance
- Reduced frequency of acute respiratory exacerbations
In one study involving patients with chronic bronchitis, those receiving Taxorest demonstrated statistically significant improvements in spirometry values and clinical symptom scores compared to control groups receiving standard therapy alone (Khavinson et al., 2006, *Advances in Gerontology*, 19, 96-103).
Bronchial Epithelium and Gene Expression
The bronchial epithelium — the cellular lining of the airways — is the first line of defense against inhaled threats. It produces mucus, drives mucociliary clearance, secretes antimicrobial peptides, and serves as a physical barrier.
Research on pulmonary peptide bioregulators has shown that short-chain peptides can modulate gene expression in bronchial epithelial cells. Specifically, studies have demonstrated effects on:
- Mucin genes — supporting appropriate (not excessive) mucus production
- Surfactant protein genes — maintaining the surfactant system critical for alveolar function
- Tight junction proteins — preserving the barrier integrity of the airway lining
- Antioxidant enzymes — protecting lung tissue from oxidative damage
Khavinson and colleagues showed that lung-specific peptides could normalize gene expression in bronchial epithelial cells that had been altered by aging or chronic inflammation, effectively restoring a more youthful transcriptional profile (Khavinson et al., 2014, *Advances in Gerontology*, 4(3), 167-173).
Respiratory Immune Defense
The lungs house their own immune system — the pulmonary mucosal immune network. This includes alveolar macrophages (the "dust cells" that engulf inhaled particles), secretory IgA antibodies, and a variety of immune cells distributed throughout the lung tissue.
Age-related decline in pulmonary immunity is a major reason why respiratory infections are so dangerous for elderly populations. Pneumonia remains a leading cause of death in people over 65.
Research on peptide bioregulators has shown immune-modulating effects in respiratory tissue. Short peptides can enhance the functional activity of alveolar macrophages and support secretory IgA production in bronchial mucosa (Khavinson et al., 2002, *Bulletin of Experimental Biology and Medicine*, 133(6), 544-547). This suggests that pulmonary peptide bioregulators may help maintain the lung's own immune defenses.
Oxidative Stress and Lung Aging
The lungs are uniquely vulnerable to oxidative stress because of their constant exposure to oxygen and environmental oxidants. This oxidative burden drives many of the cellular changes we see in aging lungs:
- DNA damage in alveolar cells
- Lipid peroxidation of cell membranes
- Protein carbonylation affecting enzyme function
- Mitochondrial damage reducing cellular energy production
Peptide bioregulators have been shown to enhance endogenous antioxidant defense systems in lung tissue. Studies demonstrate upregulation of superoxide dismutase (SOD), catalase, and glutathione peroxidase expression in pulmonary cells treated with lung-specific peptides (Anisimov et al., 2012, *Advances in Gerontology*, 2(2), 114-121).
This is important because rather than providing exogenous antioxidants (which have shown mixed results in clinical trials), peptide bioregulators appear to support the cell's own antioxidant machinery — a fundamentally different and potentially more effective approach.
Who Might Consider Taxorest?
Based on the published research and my clinical understanding, individuals who may be interested in pulmonary peptide support include:
- Adults over 40 who want to proactively support lung function
- People living in urban environments with chronic pollution exposure
- Former smokers whose lung tissue carries the legacy of past damage
- Those with occupational exposures (construction, manufacturing, agriculture)
- Active adults and athletes who want to optimize respiratory capacity
- People approaching or in their senior years who want to maintain respiratory resilience against infections
Complementary Respiratory Support Strategies
As always, I advocate for a comprehensive approach:
- Stop smoking and avoid secondhand smoke — the single most important thing for lung health
- Exercise regularly — aerobic activity strengthens respiratory muscles and improves lung efficiency
- Practice deep breathing — diaphragmatic breathing exercises help maintain lung capacity
- Maintain good indoor air quality — air purifiers, proper ventilation, reducing chemical exposures
- Stay hydrated — adequate fluid intake keeps bronchial mucus at optimal viscosity
- Anti-inflammatory nutrition — omega-3s, flavonoids, and vitamin C all support respiratory health
- Annual flu vaccination — protecting the lungs from infectious insult (especially for those 65+)
Taxorest is designed to complement these strategies by supporting the cells themselves.
How Taxorest Is Used
Nature's Marvels Taxorest provides 20 HPMC vegan capsules per box. The standard protocol from the peptide bioregulator literature is 1-2 capsules daily with meals, taken in 10-30 day cycles, repeated 2-3 times per year.
Some practitioners recommend combining Taxorest with the thymus bioregulator (Vladonix) for comprehensive respiratory immune support, since the thymus and lungs work closely together in immune defense.
My Perspective as a Respiratory Care Nurse
I have suctioned airways, titrated supplemental oxygen, and coached patients through pulmonary rehabilitation. I know firsthand how devastating respiratory decline can be — and how difficult it is to regain function once it is lost.
What draws me to the Taxorest research is the specificity. These are not generic "lung support" vitamins. They are tissue-specific peptides — 2-4 amino acids long — designed to interact with the DNA of pulmonary cells. The over 40 years of Khavinson research backing this approach gives it a scientific foundation that few supplement categories can match.
Lung function decline with age is not inevitable at the rate most people experience it. With the right combination of lifestyle choices, environmental awareness, and targeted peptide support, there is every reason to believe we can preserve respiratory function far better than the average trajectory suggests.
Explore Taxorest and the complete Nature's Marvels bioregulator line in our [shop](/shop).
---
References
- Sharma, G., & Goodwin, J. (2006). Effect of aging on respiratory system physiology and immunology. *Clinical Interventions in Aging*, 1(3), 253-260.
- Khavinson, V. Kh., et al. (2006). Peptide bioregulators in the management of chronic bronchitis. *Advances in Gerontology*, 19, 96-103.
- Khavinson, V. Kh., et al. (2014). Peptide regulation of gene expression in bronchial epithelium. *Advances in Gerontology*, 4(3), 167-173.
- Khavinson, V. Kh., et al. (2002). Peptide bioregulators modulate immune status in elderly patients. *Bulletin of Experimental Biology and Medicine*, 133(6), 544-547.
- Anisimov, V. N., et al. (2012). Peptide bioregulators and aging. *Advances in Gerontology*, 2(2), 114-121.
---
*This article is for informational and educational purposes only and is not intended as medical advice. It is not meant to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new supplement regimen. These statements have not been evaluated by the Food and Drug Administration.*